Aardvark Therapeutics, Inc.: Aardvark Therapeutics Announces Pricing of Initial Public Offering
Aardvark Therapeutics, Inc. ("Aardvark") (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics ...
Trainer Joe Pride has designs of black type races for his lightly-raced mare Weeping Woman
The Everest winning trainer Joe Pride is confident Weeping Woman is certain to tackle bigger things than Friday night’s ...
Aardvark Therapeutics Announces Pricing of Initial Public Offering
SAN DIEGO, Feb. 12, 2025 (GLOBE NEWSWIRE) -- (“Aardvark”) (Nasdaq: AARD), a clinical-stage biopharmaceutical company focused on developing novel, small-molecule therapeutics to activate innate ...